Difficulty: Medium
Average Score: 94%
Testbank
A clinic nurse is working with a patient who has a long-standing diagnosis of polycythemia vera. How can the nurse best gauge the course of the patients disease?
Correct answer
D
Rationale
Follow the trends of the patients hematocrit.
Monitoring hematocrit levels is crucial in polycythemia vera, as it directly reflects the concentration of red blood cells in the bloodstream. Regular assessments of hematocrit help gauge disease progression and the effectiveness of treatments, allowing for timely interventions to prevent complications associated with elevated red blood cell mass.
A: Document the color of the patients palms and face during each visit. This observation is not a reliable indicator of disease progression in polycythemia vera, as it does not provide quantitative data on blood cell levels or overall health.
B: Follow the patients erythrocyte sedimentation rate over time. While this rate can indicate inflammation, it is not specific to polycythemia vera and does not effectively measure the disease's progression or response to treatment.
C: Document the patients response to erythropoietin injections. Although important for treatment management, this option does not provide a comprehensive picture of the disease's overall status and progression over time.
Monitoring hematocrit levels is crucial in polycythemia vera, as it directly reflects the concentration of red blood cells in the bloodstream. Regular assessments of hematocrit help gauge disease progression and the effectiveness of treatments, allowing for timely interventions to prevent complications associated with elevated red blood cell mass.
A: Document the color of the patients palms and face during each visit. This observation is not a reliable indicator of disease progression in polycythemia vera, as it does not provide quantitative data on blood cell levels or overall health.
B: Follow the patients erythrocyte sedimentation rate over time. While this rate can indicate inflammation, it is not specific to polycythemia vera and does not effectively measure the disease's progression or response to treatment.
C: Document the patients response to erythropoietin injections. Although important for treatment management, this option does not provide a comprehensive picture of the disease's overall status and progression over time.